Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment
Cystic fibrosis (CF) is a genetic disease in which the battle between pulmonary infection and inflammation becomes the major cause of morbidity and mortality. We have previously shown that human MSCs (hMSCs) decrease inflammation and infection in the in vivo murine model of CF. The studies in this p...
Saved in:
Main Authors: | Morgan T. Sutton, David Fletcher, Santosh K. Ghosh, Aaron Weinberg, Rolf van Heeckeren, Sukhmani Kaur, Zhina Sadeghi, Adonis Hijaz, Jane Reese, Hillard M. Lazarus, Donald P. Lennon, Arnold I. Caplan, Tracey L. Bonfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/5303048 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protease-activated receptor 1 in the pathogenesis of cystic fibrosis
by: Sarath Ranganathan, et al.
Published: (2025-01-01) -
Inflammation in Cystic Fibrosis
Published: (1996-01-01) -
Laryngeal Preservation in Managing Advanced Tracheal Adenoid Cystic Carcinoma
by: Thavakumar Subramaniam, et al.
Published: (2015-01-01) -
Lobectomy in Patients with Cystic Fibrosis
by: Shahid I Sheikh, et al.
Published: (2014-01-01) -
Pseudomonas cepacia in cystic fibrosis
by: Ronald Gold
Published: (1993-01-01)